DUNHAM TRUST Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
DUNHAM TRUST Co's REGN Position: Q3 2026 in Review
DUNHAM TRUST Co held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 1,200 shares worth $910K. The position accounts for 0.41% of the portfolio, ranked #27.
DUNHAM TRUST Co first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $926K in Q4 2025. 1,409 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- DUNHAM TRUST Co held 1,200 shares of Regeneron Pharmaceuticals worth $910K as of Q3 2026.
- DUNHAM TRUST Co left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
- Regeneron Pharmaceuticals made up 0.41% of DUNHAM TRUST Co's portfolio in Q3 2026, its #27 holding.
- DUNHAM TRUST Co first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- DUNHAM TRUST Co's Regeneron Pharmaceuticals position peaked at $926K in Q4 2025.
- 1,409 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on DUNHAM TRUST Co's 13F filing for Q3 2026, filed 16 Nov 2026.